drugset / Trial / NCT04069065
Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of conversion to TacroBell slow-release cap.(Once-daily Tacrolimus) in patients undergoing maintenance therapy with Twice-Daily Tacrolimus after liver transplantation.
Timeline
- Start
- 2019-07-31
- Primary completion
- 2021-02-22
- Completion
- 2021-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 100 % | Oral |
Indications
No indication recorded.